Gain Therapeutics, Inc. (GANX) vs Telomir Pharmaceuticals, Inc. (TELO)

Gain Therapeutics, Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Gain Therapeutics, Inc. and Telomir Pharmaceuticals, Inc. are of similar size ($83.2M and $80.3M). Across the 9 metrics below, Telomir Pharmaceuticals, Inc. leads on 5 and Gain Therapeutics, Inc. on 4.

Valuation

Metric GANX TELO Biotechnology median
P/E n/m n/m 7.88
P/S 397.40 n/m 11.47
P/B 6.87 14.75 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 332.17 n/m 10.73
Earnings yield (27.62%) (74.59%) (28.84%)
Free cash flow yield (24.45%) (6.62%) (23.03%)

Profitability

Metric GANX TELO Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (268.30%) (1,885.50%) (57.72%)
Return on assets (159.22%) (1,678.31%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GANX TELO Biotechnology median
Revenue growth (TTM) 18.36% — 5.64%
EPS growth (last fiscal year) 31.46% 41.07% —
Revenue growth, 5-year CAGR 21.79% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GANX TELO Biotechnology median
Debt to equity 0.03 0.03 0.00
Current ratio 4.36 16.14 4.73
Net debt to EBITDA 1.10 0.69 0.96

Dividend

Metric GANX TELO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric GANX TELO Biotechnology median
Market cap 80.30m 83.22m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack